Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases

NCT05812534 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Brain Metastases

Interventions

DRUG: Cadonilimab

Sponsor

Second Affiliated Hospital of Nanchang University

Collaborators

[object Object]
[object Object]